The effect of distal polyneuropathy on balance disorder in patients with diabetes
https://doi.org/10.21518/2079-701X-2013-12-118-119
Abstract
According to various authors, the prevalence of sensitive ataxia (due to proprioceptive dysfunction) in patients with diabetes mellitus (DM) equals 10 to 90% [1, 2]. The great variability of data from different studies suggests that the question is understudied. P.R. Cavanagh et al. found that patients with DM and distal symmetric sensorimotor polyneuropathy (DPN) have walking injuries 15 times more often (falls, fractures, sprained ankle, cuts and bruises) than diabetic patients without DPN [3]. Brach J.S. et al. noted the following factors leading to balance disorders in patients with DM: sensory deficit, decreased leg muscle strength and lesions of the CNS [4]. At the same time, balance disorder in patients with diabetes resulting from distal polyneuropathy received has been given much less attention compared with falls caused by autonomic neuropathy and orthostatic hypotension [5].
About the Authors
О. S. Fedorova
Federal Bureau of Medical and Social Examination, Moscow
Russian Federation
Russian Federation
I. V. Gurieva
Federal Bureau of Medical and Social Examination, Moscow
Russian Federation
Russian Federation
I. A. Strokov
First Moscow State Medical University named after I.M. Sechenov
Russian Federation
Russian Federation
References
1. Lafond D, Corriveau H, Prince F. Postural control mechanisms during quiet standing in patients with diabetic sensory neuropathy. Diabetes Care, 2004;27(1):173-178.
2. Vinik AI, Park TS, Stansberry KB, Pittenger GL. Diabetic neuropathies. Diabetologia, 2000;43:957-973.
3. Cavanagh PR, Derr JA, Ulbrecht JS, Maser RE, Orchard TJ. Problems with gait and posture in neuropathic patients with insulin-dependent diabetes mellitus. Diabet Med., 1992;9:469-474.
4. Brach JS, Talkowski JB, Strotmeyer ES, Newman AB. Diabetes mellitus and gait dysfunction: possible explanatory factors. Physical therapy, 2008;88(11):1365-1374.
5. Centomo H, Termoz N, Savoie S, Beliveau L, Prince F. Postural control following a self-intiated reaching task in type 2 diabetic patients and age-matched controls. Gait & Posture, 2007;25:509-514.
6. Emery P. Optimizing outcomes in patients with rheumatoid arthritis and an inadequate response to anti-TNF treatment. Rheumatology (Oxford). 2012;51(Suppl 5):22-30.
7. Tak PP. A personalized medicine approach to biologic treatment of rheumatoid arthritis: a preliminary treatment algorithm. Rheumatology (Oxford). 2012;51:600-9.
8. Moots RJ, Naisbett-Groet B. The efficacy of biologic agents in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors: a systematic review. Rheumatology (Oxford). 2012 Dec;51(12):2252-61.
9. Simsek I. Predictors of response to TNF inhibitors in rheumatoid arthritis - do we have new tools for personalized medicine? Bull NYUHosp Jt Dis, 2012;70:187-90.
10. Большая советская энциклопедия. М.: Советская энциклопедия. 1969-1978.
11. Kyttaris V. Kinase inhibitors: a new class of antirheumatic drugs. Drug Design. Development and Therapy, 2012;6:245-250.
12. Riccaboni M, Bianchi I, Petrillo P. Spleen tyrosine kinases: biology, therapeutic targets and drugs. DrugDiscov Today. 2010;15:517-530. Park SR, Speranza G, Piekarz R, et al. A multi-histology trial of fostamatinib in patients with advanced colorectal, non-small cell lung, head and neck, thyroid, and renal cell carcinomas, and pheochromocytomas. Cancer Chemother Pharmacol., 2013;71:981-90.
13. Nijjar JS, Tindell A, Mclnnes IB, Siebert S. Inhibition of spleen tyrosine kinase in the treatment of rheumatoid arthritis. Rheumatology (Oxford). 2013;52:1556-62.
14. Genovese MC, Kavanaugh A, Weinblatt ME, et al. An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents. Arthritis Rheum. 2011;63:337-345.
15. Becker S, Groner B, Muller CW. Three-dimentional structure of the STAT3b homodimer bound to DNA. Nature, 1998;394:145-151.
16. Guschin D, Rogers N, Briscoe J, et al. A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6. EMBO J. 1995;14:1421-9.
Review
For citations:
Fedorova ОS, Gurieva IV, Strokov IA. The effect of distal polyneuropathy on balance disorder in patients with diabetes. Meditsinskiy sovet = Medical Council. 2013;(12):118-119. (In Russ.) https://doi.org/10.21518/2079-701X-2013-12-118-119
Views:
435
Email this article 